Anish Scaria

Featured in:

Articles

Effectiveness of XBB.1.5 monovalent COVID-19 vaccine against COVID-19 mortality in Australians aged 65 years and older during August 2023 to February 2024

Aug 13, 2024 | medrxiv.org | Bette Liu |Sandrine Stepien |Kristine Macartney |Anish Scaria

BL's institution receives grant funding from the Australian National Health and Medical Research Council and the Medical Research Future Fund and Wellcome Trust. From 2019-2023 BL was a member of the Australian Technical Advisory Group on Immunisation. KM's institution has received funding from Australian and State Government Departments of Health, Australian National Health and Medical Research Council, GAVI, WHO and Wellcome Trust. KM has served as an expert witness for State Governments.

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.